Jay Olson analyst OPPENHEIMER

Currently out of the existing stock ratings of Jay Olson, 281 are a BUY (93.05%), 20 are a HOLD (6.62%), 1 are a SELL (0.33%).

Jay Olson

Work Performance Price Targets & Ratings Chart

Analyst Jay Olson works at OPPENHEIMER with a stock forecast success ratio of 46.46% fulfilled within 156.85 days on average.

Jay Olson’s has documented 669 price targets and ratings displayed on 41 stocks. The coverage is on Healthcare, Industrials, Financial Services sectors.

Most recent stock forecast was given on VKTX, Viking Therapeutics at 27-Mar-2024.

Wall Street Analyst Jay Olson

Analyst best performing recommendations are on NKTR (NEKTAR THERAPEUTICS).
The best stock recommendation documented was for NKTR (NEKTAR THERAPEUTICS) at 11/7/2019. The price target of $20 was fulfilled within 1 day with a profit of $1.3 (6.95%) receiving and performance score of 69.52.

Average potential price target upside

ACAD ACADIA Pharmaceuticals AMGN Amgen BCYC Bicycle Therapeutics Ltd BIIB Biogen CBAY Cymabay Therapeu CRSP Crispr Therapeutics AG EDIT Editas Medicine FREQ Frequency Therapeutics ICPT Intercept Pharmaceuticals MRTX Mirati Ther NBIX Neurocrine Biosciences NTLA Intellia Therapeutics PRTA Prothena plc PTLA Portola Pharmaceuticals SAGE Sage Therapeutic SGEN Seagen SRRA Sierra Oncology TXMD TherapeuticsMD ENTA Enanta Pharmaceuticals AXON Axon Enterprise . AYLA Ayala Pharmaceuticals  DNLI Denali Therapeutics ETN Eaton PLC EXEL Exelixis FOCS Focus Financial Partners INCY yte JSPR Jasper Therapeutics KRTX Karuna Therapeutics MDGL Madrigal Pharmaceuticals NKTR Nektar Therapeutics BIVI Biovie CINC CinCor Pharma ETNB 89bio CGTX Cognition Therapeutics MDCO The Medicines Company RLMD Relmada Therapeutics RVMD Revolution Medicines VKTX Viking Therapeutics VYGR Voyager Therapeutics MRNS Marinus Pharmaceuticals GLTO Galecto 

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

25

$7.2 (40.45%)

29

28 days ago

5/8 (62.5%)

$7.16 (40.13%)

26

Buy

30

$12.2 (68.54%)

40

1 months 9 days ago

16/19 (84.21%)

$10.44 (53.37%)

184

Buy

39

$21.2 (119.10%)

40

1 months 25 days ago

6/10 (60%)

$15.25 (64.21%)

94

Buy

33

$15.2 (85.39%)

33

1 months 25 days ago

8/19 (42.11%)

$9.25 (38.95%)

119

Buy

36

$18.2 (102.25%)

1 months 25 days ago

0/1 (0%)

$12.25 (51.58%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Jay Olson is most bullish on?

Potential upside of $85.05 has been obtained for BIIB (BIOGEN)

Which stock is Jay Olson is most reserved on?

Potential downside of $0.17 has been obtained for KRTX (KARUNA THERAPEUTICS)

What Year was the first public recommendation made by Jay Olson?

On 2016

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?